← Back
$RCKT All transactions

ROCKET PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

61,963

Price

$0

Filed

Feb 13

Insider

Name

Rizvi Syed Ali-aamir

Title

Chief Medical Officer

CIK

0001897621

Roles

Officer

Transaction Details

Transaction Date

2026-02-11

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

407,874

Footnotes

Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. | Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years. | This option represents a right to purchase a total of 93,037 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

Filing Info

Accession No.

0001140361-26-005409

Form Type

4

Issuer CIK

0001281895

Rizvi Syed Ali-aamir's History

Date Ticker Type Value
2026-02-11 RCKT A $0
2026-02-11 RCKT A $0
2025-10-06 RCKT A $0
2025-10-06 RCKT A $0
2025-10-06 RCKT A $0

Other Insiders at RCKT (90d)

Insider Bought Sold Last
Militello John
See Remarks
$16K 2026-02-18
Wilson Martin
General Counsel
$45K 2026-02-18
Shah Gaurav
CEO
$61K 2026-02-18
Rizvi Syed Ali-aamir
Chief Medical Officer
2026-02-11
Chaudhuri Sarbani
See Remarks
2026-02-11
Stevens Christopher James
Chief Operating Officer
2026-02-11